Antonenko, S.V., and G.D. Telegeev. “Inhibition of USP1, a New Partner of Bcr-Abl, Results in Decrease of Bcr-Abl Level in K562 Cells”. Experimental Oncology, vol. 42, no. 2, June 2023, pp. 109-14, doi:10.32471/exp-oncology.2312-8852.vol-42-no-2.14533.